Professor of Medicine, Paracelsus Medical University Salzburg
Verified email at
Cited by
Cited by
Endocrine therapy plus zoledronic acid in premenopausal breast cancer
M Gnant, B Mlineritsch, W Schippinger, G Luschin-Ebengreuth, ...
New England Journal of Medicine 360 (7), 679-691, 2009
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 …
R Jakesz, W Jonat, M Gnant, M Mittlboeck, R Greil, C Tausch, J Hilfrich, ...
The Lancet 366 (9484), 455-462, 2005
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
J Bennouna, J Sastre, D Arnold, P Österlund, R Greil, E Van Cutsem, ...
The lancet oncology 14 (1), 29-37, 2013
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
A Engert, A Plütschow, HT Eich, A Lohri, B Dörken, P Borchmann, ...
New England Journal of Medicine 363 (7), 640-652, 2010
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor–positive breast cancer
J Baselga, V Semiglazov, P Van Dam, A Manikhas, M Bellet, ...
Journal of Clinical Oncology 27 (16), 2630-2637, 2009
Monoclonal gammopathy of undetermined significance: natural history in 241 cases
RA Kyle
The American journal of medicine 64 (5), 814-826, 1978
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
NU Lin, V Diéras, D Paul, D Lossignol, C Christodoulou, HJ Stemmler, ...
Clinical cancer research 15 (4), 1452-1459, 2009
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 …
DV Engert A, Haverkamp H, Kobe C, Markova J, Renner C, GHS Group, ...
LANCET 329 (9828), 1791-9, 2012
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
M Filipits, M Rudas, R Jakesz, P Dubsky, F Fitzal, CF Singer, O Dietze, ...
Clinical Cancer Research 17 (18), 6012-6020, 2011
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3
E Van Cutsem, R Labianca, G Bodoky, C Barone, E Aranda, B Nordlinger, ...
Journal of Clinical Oncology 27 (19), 3117-3125, 2009
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
M Gnant, B Mlineritsch, H Stoeger, G Luschin-Ebengreuth, D Heck, ...
The lancet oncology 12 (7), 631-641, 2011
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group …
HT Eich, V Diehl, H Görgen, T Pabst, J Markova, J Debus, A Ho, B Dörken, ...
Journal of clinical oncology 28 (27), 4199-4206, 2010
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
M Gnant, G Pfeiler, PC Dubsky, M Hubalek, R Greil, R Jakesz, V Wette, ...
The Lancet 386 (9992), 433-443, 2015
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
M Gnant, B Mlineritsch, G Luschin-Ebengreuth, F Kainberger, ...
The lancet oncology 9 (9), 840-849, 2008
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised …
B Burtness, KJ Harrington, R Greil, D Souličres, M Tahara, G de Castro Jr, ...
The Lancet 394 (10212), 1915-1928, 2019
Randomized phase II study of the anti–epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple …
J Baselga, P Gómez, R Greil, S Braga, MA Climent, AM Wardley, ...
Journal of clinical oncology 31 (20), 2586, 2013
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO …
R Porschen, HT Arkenau, S Kubicka, R Greil, T Seufferlein, W Freier, ...
Journal of Clinical Oncology 25 (27), 4217-4223, 2007
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a
R Jakesz, R Greil, M Gnant, M Schmid, W Kwasny, E Kubista, ...
Journal of the National Cancer Institute 99 (24), 1845-1853, 2007
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response
M Cazzola, D Messinger, V Battistel, D Bron, R Cimino, L Enller-Ziegler, ...
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal …
M Gnant, M Filipits, R Greil, H Stoeger, M Rudas, Z Bago-Horvath, ...
Annals of oncology 25 (2), 339-345, 2014
The system can't perform the operation now. Try again later.
Articles 1–20